w w w . o f d t . f rw w w . o f d t . f r

Learning from the I-TREND projectHow and why set up a digital monitoring

Magali Martinez,

Agnès Cadet-Taïrou

TREND UNIT, OFDT

Poznan, 26/10/2016Co-funded by

European Union

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Focal Points usual sources

Custom and police SEIZURES

Public Health Signals

(decease, non fatal intoxication, serious

adverse effect,)

Ethnographicobservation

(Trend network in France)

Sample collection through users

(DIMS in the Netherlands)

General Population Survey or specificstatistical studies

2

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

2011, NPS waves

3

Focal Points usual sources

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

NPS TOP LIST

WS 5

Trigger

4

Usual sources

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

Technical

Folders

WS 5

Achievement

5

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

NPS TOP LIST

Online Survey

WS 4

6

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

NPS TOP LIST

Online Shops

Online Survey

WS 2

7

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

NPS TOP LIST

Online Shops

Online Survey

Chemical analysis

WS 3

8

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

NPS TOP LIST

Forums

Online Shops

Online Survey

Chemical analysis

WS 1

9

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

10

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

I-TREND’s workstreams

TechnicalFolders

Forums

Online Shops

Online Survey

Chemical analysis

Plus usual

sources !

11

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 12

Difficulties encountered

Too many…..

I-TREND is a prototype –

Greater stake was to create software

Fitted specifically for drugs researches

Cheaper !

Eg. For WS1, French projects in medical field

around 100x more expansive.

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 13

Forums software Functioning

w w w . o f d t . f r

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 14

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 15

WS1 software Functioning

Thread n°1

Thread n°2

Thread n°3

Thread n°4

……

AKB-48

3-MMC

Purchase

Adress

MXE

Arylcyclohexylamine

Dissociative

Cathinone

Stimulant

1st level2nd level

NPS Names

3rd levels

Categories

Thematic

w w w . o f d t . f rw w w . o f d t . f r

Purpose

Detection of peaks in the number of

views/ activity for being accurately

informed about which NPS attract users’

attention

16

w w w . o f d t . f rw w w . o f d t . f r

Purpose

be informed of:

Evolution of the audience : stable,

falling, decreasing,

Keep tracks of events – memory of

the past

Identify the trigger of observed

changes

17

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 18

Results -Information on the audience structure

Very few compounds are discussed and fewer are

elected

• Eg. 112 cathinones at EU level,

The most famous NPS on forums exceed others

NPS several times more

NPS are split among 3 or 4 groups of

importance / audience

UK FR PL NL

10 18 34 18

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 19

Cathinones in France

1st Group < 25 views

2nd Group < 100 views

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 20

Cathinones in France, plus 3-MMC

3rd Group > 100 views

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Users interest is very stable over the time,

Following examples based on EDND families and not

on substances – for better visibility

Results -Information on the audience structure

21

w w w . o f d t . f rw w w . o f d t . f r

In the Netherlands - Phenethelamines

22

Threads on 4-FA

w w w . o f d t . f rw w w . o f d t . f r

In Poland - Cathinones

23

Threads on 4-MMC

Threads on 3-MMC

w w w . o f d t . f rw w w . o f d t . f r

In The United Kingdom

24

Threads on Branded

products

Threads on Etizolam

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Each country has its “national preferences”

UK, Branded Products, etizolam, ethylphenidate,

AL-LAD, LSZ.

NL, 4-FA, 6-APB and 2C-B.

PL, 4-MMC and 3-MMC, Branded Product and mix

of synthetic cannabinoids.

FR, 3-MMC and synthetic cannabinoids with e-

liquid form

Results - Information on each national drug context

25

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Forums are different

More or less open toward online vendors

More or less eager to accept branded

products

Publicity on or the right to use branded

names vs chemical names in online

discussions

Frequented by different type of users

Results -Information on each national drug context

26

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 27w w w . o f d t . f r

E

Psychonaut

USERS in

PRECARIOUS

situation

27

Sub-groups observed through francophone forums and real ethnographic observations

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Sub-groups of users do not discover

each NPS at the same time

Changes could happen when one

sub-group of users is about to

discovering one NPS, in regard with its

consumption scheme

Eg. Alpha-PVP

Results -Information on each national drug context

28

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Alpha-PVP in France, Poland and the United-Kingdom

1st period

Sold online

E-psychonaut

disinterest

3rd period

New readers,

New types of

comments

2nd period

Start to be

sold in

street

29

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Changes could also be linked with new

consumption tools

Eg. 5F-AKB-48 e-liquid form in France

Results -Information on each national drug context

30

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

In France EDND Families

Just two

E-liquid

discussions on

> 800 threads

31

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

It could be obvious to say today that NPS

are

A global phenomenon, with local

particularities

Could be in stabilisation phase

But

Hardly demonstrable and few

documented, whereas there is a need to

understand,

Conclusion

32

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Why one NPS spreads across one

country and not in another ?

Which NPS are likely to spread in lot of

countries ?

Short term questions

Should we ban NPS in group or not ?

And if not, which one should be banned ?

Eg. MDPV, synthetic opiates…. contrasted national

situations.

Conclusion

33

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Long term question

NPS could become or not a

“significant” trend in general population ?

If not for the Millennial generation, what

about the Z Generation ?

Conclusion

34

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r

Monitoring digital spaces as we do with

low threshold services, prescription drugs,

school, nightlife settings, is a stake ahead

of us

35

w w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f rw w w . o f d t . f r 36w w w . o f d t . f r

www.i-trend.euThanks for your attentionmagali.martinez@ofdt.fr

European project JUST/2012/DPIP/AG/3641 co-financed by the

Drug Prevention and Information Program of the European Union.The author declares no conflicts of interest.

Co-funded by

European Union

36